Tacrolimus-Induced Neurotoxicity After Transplant: A Literature Review.
Verona P, Edwards J, Hubert K, Avorio F, Re VL, Di Stefano R, Carollo A, Johnson H, Provenzani A.
Drug Saf. 2024 May;47(5):419-438. doi: 10.1007/s40264-024-01398-5. Epub 2024 Feb 14.
Clinical hepatotoxicity associated with antifungal agents.
Kyriakidis I, Tragiannidis A, Munchen S, Groll AH.
Expert Opin Drug Saf. 2017 Feb;16(2):149-165. doi: 10.1080/14740338.2017.1270264. Epub 2016 Dec 16.
Management of toxicities of immune checkpoint inhibitors.
Spain L, Diem S, Larkin J.
Cancer Treat Rev. 2016 Mar;44:51-60. doi: 10.1016/j.ctrv.2016.02.001. Epub 2016 Feb 6.
Clinical management of patients with drug-induced liver injury (DILI).
Björnsson ES.
United European Gastroenterol J. 2021 Sep;9(7):781-786. doi: 10.1002/ueg2.12113. Epub 2021 Jun 28.
Macrolides: From Toxins to Therapeutics.
Lenz KD, Klosterman KE, Mukundan H, Kubicek-Sutherland JZ.
Toxins (Basel). 2021 May 12;13(5):347. doi: 10.3390/toxins13050347.
[Macrolides and ketolides].
Cobos-Trigueros N, Ateka O, Pitart C, Vila J.
Enferm Infecc Microbiol Clin. 2009 Aug-Sep;27(7):412-8. doi: 10.1016/j.eimc.2009.06.002. Epub 2009 Jul 21.
[Campylobacter].
Tsunematsu S.
Nihon Rinsho. 2012 Aug;70(8):1352-5.
Toxic neuropathy.
Umapathi T, Chaudhry V.
Curr Opin Neurol. 2005 Oct;18(5):574-80. doi: 10.1097/01.wco.0000180158.34713.aa.
Characteristics of ivermectin toxicity in patients taking veterinary and human formulations for the prevention and treatment of COVID-19.
Hoang R, Temple C, Correia MS, Clemons J, Hendrickson RG.
Clin Toxicol (Phila). 2022 Dec;60(12):1350-1355. doi: 10.1080/15563650.2022.2134788. Epub 2022 Nov 14.
Telithromycin.
Turner M, Corey GR, Abrutyn E.
Ann Intern Med. 2006 Mar 21;144(6):447-8. doi: 10.7326/0003-4819-144-6-200603210-00014.
